Artigos de revistas sobre o tema "Β1-Blockers"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Β1-Blockers".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Bennett, Miriam, Catherina L. Chang, Michael Tatley, Ruth Savage e Robert J. Hancox. "The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports". ERJ Open Research 7, n.º 1 (janeiro de 2021): 00801–2020. http://dx.doi.org/10.1183/23120541.00801-2020.
Texto completo da fontedo Vale, Gabriel T., Carla S. Ceron, Natália A. Gonzaga, Janaina A. Simplicio e Júlio C. Padovan. "Three Generations of β-blockers: History, Class Differences and Clinical Applicability". Current Hypertension Reviews 15, n.º 1 (29 de janeiro de 2019): 22–31. http://dx.doi.org/10.2174/1573402114666180918102735.
Texto completo da fonteKaroli, N. A., e A. P. Rebrov. "Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease". Kardiologiia 61, n.º 10 (30 de outubro de 2021): 89–98. http://dx.doi.org/10.18087/cardio.2021.10.n1119.
Texto completo da fonteStănciulescu, Maria-Corina, Marius-Călin Popoiu, Anca Maria Cîmpean, Vlad-Laurentiu David, Rodica Heredea, Simona Cerbu e Eugen-Sorin Boia. "Expression of β1 adrenergic receptor in vascular anomalies in children". Journal of International Medical Research 49, n.º 9 (setembro de 2021): 030006052110477. http://dx.doi.org/10.1177/03000605211047713.
Texto completo da fonteBarcella, Carlo A., Talip E. Eroglu, Michiel Hulleman, Asger Granfeldt, Patrick C. Souverein, Grimur H. Mohr, Rudolph W. Koster et al. "Association of beta-blockers and first-registered heart rhythm in out-of-hospital cardiac arrest: real-world data from population-based cohorts across two European countries". EP Europace 22, n.º 8 (28 de junho de 2020): 1206–15. http://dx.doi.org/10.1093/europace/euaa124.
Texto completo da fonteGrande, Fedora, Anna De Bartolo, Maria Antonietta Occhiuzzi, Anna Caruso, Carmine Rocca, Teresa Pasqua, Alessia Carocci, Vittoria Rago, Tommaso Angelone e Maria Stefania Sinicropi. "Carbazole and Simplified Derivatives: Novel Tools toward β-Adrenergic Receptors Targeting". Applied Sciences 11, n.º 12 (13 de junho de 2021): 5486. http://dx.doi.org/10.3390/app11125486.
Texto completo da fonteArtym, Vira V., e Howard R. Petty. "Molecular Proximity of Kv1.3 Voltage-gated Potassium Channels and β1-Integrins on the Plasma Membrane of Melanoma Cells". Journal of General Physiology 120, n.º 1 (10 de junho de 2002): 29–37. http://dx.doi.org/10.1085/jgp.20028607.
Texto completo da fonteSingh, Bramah N. "β-Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Compounds: An Overview". Journal of Cardiovascular Pharmacology and Therapeutics 10, n.º 4_suppl (outubro de 2005): S3—S14. http://dx.doi.org/10.1177/10742484050100i402.
Texto completo da fonteWinther, K., e C. Hedman. "Beta-Adrenoceptor Blockade, Platelets, and Rheologic Factors". Cephalalgia 6, n.º 5_suppl (maio de 1986): 33–40. http://dx.doi.org/10.1177/03331024860060s504.
Texto completo da fonteDiniz, Gabriela Placoná, Marcela Sorelli Carneiro-Ramos e Maria Luiza Morais Barreto-Chaves. "Thyroid Hormone Increases TGF-β1 in Cardiomyocytes Cultures Independently of Angiotensin II Type 1 and Type 2 Receptors". International Journal of Endocrinology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/384890.
Texto completo da fonteClemente-Moragón, Agustín, Mónica Gómez, Rocío Villena-Gutiérrez, Doménica V. Lalama, Jaime García-Prieto, Fernando Martínez, Fátima Sánchez-Cabo, Valentín Fuster, Eduardo Oliver e Borja Ibáñez. "Metoprolol exerts a non-class effect against ischaemia–reperfusion injury by abrogating exacerbated inflammation". European Heart Journal 41, n.º 46 (7 de outubro de 2020): 4425–40. http://dx.doi.org/10.1093/eurheartj/ehaa733.
Texto completo da fonteNuttall, S. L., H. C. Routledge e M. J. Kendall. "A comparison of the β1 -selectivity of three β1 -selective β-blockers". Journal of Clinical Pharmacy and Therapeutics 28, n.º 3 (junho de 2003): 179–86. http://dx.doi.org/10.1046/j.1365-2710.2003.00477.x.
Texto completo da fonteWAJIMA, Zen'ichiro. "Future Possibilities for the Clinical Use of β1-blockers". JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA 26, n.º 4 (2006): 398–403. http://dx.doi.org/10.2199/jjsca.26.398.
Texto completo da fonteNakaya, Michio, Satsuki Chikura, Kenji Watari, Natsumi Mizuno, Koji Mochinaga, Supachoke Mangmool, Satoru Koyanagi et al. "Induction of Cardiac Fibrosis by β-Blocker in G Protein-independent and G Protein-coupled Receptor Kinase 5/β-Arrestin2-dependent Signaling Pathways". Journal of Biological Chemistry 287, n.º 42 (10 de agosto de 2012): 35669–77. http://dx.doi.org/10.1074/jbc.m112.357871.
Texto completo da fonteÁblad, Bengt, e Carl Dahlöf. "Migraine and β-Blockade: Modulation of Sympathetic Neurotransmission". Cephalalgia 6, n.º 5_suppl (maio de 1986): 7–14. http://dx.doi.org/10.1177/03331024860060s501.
Texto completo da fonteBlaauw, Erik, Frans A. van Nieuwenhoven, Peter Willemsen, Tammo Delhaas, Frits W. Prinzen, Luc H. Snoeckx, Marc van Bilsen e Ger J. van der Vusse. "Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes". American Journal of Physiology-Heart and Circulatory Physiology 299, n.º 3 (setembro de 2010): H780—H787. http://dx.doi.org/10.1152/ajpheart.00822.2009.
Texto completo da fonteAshes, Catherine, Saul Judelman, Duminda N. Wijeysundera, Gordon Tait, C. David Mazer, Gregory M. T. Hare e W. Scott Beattie. "Selective β1-Antagonism with Bisoprolol Is Associated with Fewer Postoperative Strokes than Atenolol or Metoprolol". Anesthesiology 119, n.º 4 (1 de outubro de 2013): 777–87. http://dx.doi.org/10.1097/aln.0b013e3182a17f12.
Texto completo da fontePeltenburg, Puck J., Dania Kallas, Johan M. Bos, Krystien V. V. Lieve, Sonia Franciosi, Thomas M. Roston, Isabelle Denjoy et al. "An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation 145, n.º 5 (fevereiro de 2022): 333–44. http://dx.doi.org/10.1161/circulationaha.121.056018.
Texto completo da fonteDurgaryan, Ruzan. "C0159 β1 blockers, warfarin and rhythm conversion in atrial fibrillation". Thrombosis Research 130 (outubro de 2012): S173. http://dx.doi.org/10.1016/j.thromres.2012.08.188.
Texto completo da fonteFedorov, V. N., V. P. Vdovichenko, M. K. Korsakov, V. V. Strakhov, A. A. Popova, A. I. Khokhlov e S. S. Suleymanov. "Pharmacotherapy of glaucoma in terms of evidence-based medicine". Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice, n.º 3 (20 de outubro de 2023): 44–54. http://dx.doi.org/10.37489/2588-0519-2023-3-44-54.
Texto completo da fonteGeng, Yanyan, Xiaoyu Wang e Karl L. Magleby. "Lack of negative slope in I-V plots for BK channels at positive potentials in the absence of intracellular blockers". Journal of General Physiology 141, n.º 4 (25 de março de 2013): 493–97. http://dx.doi.org/10.1085/jgp.201210955.
Texto completo da fonteYi, Sheng, Fernando Pierucci-Alves e Bruce D. Schultz. "Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway". American Journal of Physiology-Cell Physiology 305, n.º 8 (15 de outubro de 2013): C867—C876. http://dx.doi.org/10.1152/ajpcell.00121.2013.
Texto completo da fonteCasabella-Ramón, Sergi, Verónica Jiménez-Sábado, Carmen Tarifa, Sandra Casellas, Tien Tina Lu, Paloma Izquierdo-Castro, Ignasi Gich et al. "Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes". Biomedicines 10, n.º 7 (21 de julho de 2022): 1759. http://dx.doi.org/10.3390/biomedicines10071759.
Texto completo da fonteFarhoumand, Lina S., Hongtao Liu, Theodora Tsimpaki, Ulrike B. Hendgen-Cotta, Tienush Rassaf, Nikolaos E. Bechrakis, Miltiadis Fiorentzis e Utta Berchner-Pfannschmidt. "Blockade of ß-Adrenergic Receptors by Nebivolol Enables Tumor Control Potential for Uveal Melanoma in 3D Tumor Spheroids and 2D Cultures". International Journal of Molecular Sciences 24, n.º 6 (20 de março de 2023): 5894. http://dx.doi.org/10.3390/ijms24065894.
Texto completo da fonteWydra, Wioletta, e Marek Kuch. "Nebivolol – a place in the therapy of hypertension in various clinical situations". Medycyna Faktów 14, n.º 2 (30 de junho de 2021): 195–200. http://dx.doi.org/10.24292/01.mf.0221.9.
Texto completo da fonteVerdecchia, Paolo, Claudio Cavallini, Stefano Coiro, Clara Riccini e Fabio Angeli. "Certainties fading away: β-blockers do not worsen chronic obstructive pulmonary disease". European Heart Journal Supplements 23, Supplement_E (1 de outubro de 2021): E172—E176. http://dx.doi.org/10.1093/eurheartj/suab116.
Texto completo da fonteFloria, Mariana, Alexandru Florinel Oancea, Paula Cristina Morariu, Alexandru Burlacu, Diana Elena Iov, Cristina Petronela Chiriac, Genoveva Livia Baroi et al. "An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation". Pharmaceutics 16, n.º 4 (8 de abril de 2024): 517. http://dx.doi.org/10.3390/pharmaceutics16040517.
Texto completo da fonteSchnabel, Petra, Christoph Maack, Florian Mies, Stephan Tyroller, Alexander Scheer e Michael Böhm. "Binding Properties of β-Blockers at Recombinant β1-, β2-, and β3-Adrenoceptors". Journal of Cardiovascular Pharmacology 36, n.º 4 (outubro de 2000): 466–71. http://dx.doi.org/10.1097/00005344-200010000-00008.
Texto completo da fonteMizogami, Maki, Ko Takakura e Hironori Tsuchiya. "The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers". European Journal of Anaesthesiology 27, n.º 9 (setembro de 2010): 829–34. http://dx.doi.org/10.1097/eja.0b013e32833bf5e4.
Texto completo da fonte&NA;. "The interactivities with lipid membranes differentially characterize selective and nonselective β1-blockers". European Journal of Anaesthesiology 29, n.º 5 (maio de 2012): 255. http://dx.doi.org/10.1097/eja.0b013e328353b02b.
Texto completo da fonteBrizzi, Vittorio, Marco Francioli, Mario Brufani, Luigi Filocamo, Giancarlo Bruni e Paola Massarelli. "Synthesis, binding affinity and selectivity of new β1- and β2-adrenoceptor blockers". Il Farmaco 54, n.º 11-12 (novembro de 1999): 713–20. http://dx.doi.org/10.1016/s0014-827x(99)00077-4.
Texto completo da fonteRizos, Ioannis K., James N. Tsoporis, Ioannis K. Toumpoulis, Vasileios Salpeas, Shehla Izhar, Angelos G. Rigopoulos, Eleftherios A. Sakadakis e Thomas G. Parker. "Antiapoptotic Effect of β1 Blockers in Ascending Thoracic Aortic Smooth Muscle Cells". Journal of Cardiovascular Pharmacology 72, n.º 2 (agosto de 2018): 86–96. http://dx.doi.org/10.1097/fjc.0000000000000596.
Texto completo da fonteChaudhari, Sarika, Weizu Li, Yanxia Wang, Hui Jiang, Yuhong Ma, Mark E. Davis, Jonathan E. Zuckerman e Rong Ma. "Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cells". American Journal of Physiology-Renal Physiology 313, n.º 3 (1 de setembro de 2017): F729—F739. http://dx.doi.org/10.1152/ajprenal.00483.2016.
Texto completo da fonteKähönen, Mika, Ritva Ylitalo, Tiit Kööbi, Väinö Turjanmaa e Pauli Ylitalo. "Influences of nonselective, β1-selective and vasodilatory β1-selective β-blockers on arterial pulse wave velocity in normotensive subjects". General Pharmacology: The Vascular System 35, n.º 4 (outubro de 2000): 219–24. http://dx.doi.org/10.1016/s0306-3623(01)00109-4.
Texto completo da fonteMiaron, J. O. O., e R. J. Christopherson. "Metabolic responses of the whole body, portal-drained viscera and hindquarter to adrenaline infusion: Effects of nonselective and selective β-adrenoceptor blockade". Canadian Journal of Animal Science 77, n.º 2 (1 de junho de 1997): 307–16. http://dx.doi.org/10.4141/a94-082.
Texto completo da fonteZhang, Y. Clare, Leping Shen e M. Ian Phillips. "An Antisense β1-Reducer: Repeated Administration Reduces Hypertension and Cardiac Hypertrophy Persistently Without Toxicity or Immune Response". Hypertension 36, suppl_1 (outubro de 2000): 691. http://dx.doi.org/10.1161/hyp.36.suppl_1.691.
Texto completo da fonteOngali, Brice, Nektaria Nicolakakis, Xin-Kang Tong, Clotilde Lecrux, Hans Imboden e Edith Hamel. "Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways". Canadian Journal of Physiology and Pharmacology 96, n.º 5 (maio de 2018): 527–34. http://dx.doi.org/10.1139/cjpp-2017-0640.
Texto completo da fontePark, Soo Hyun, e Ho Jae Han. "The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells". American Journal of Physiology-Renal Physiology 282, n.º 2 (1 de fevereiro de 2002): F228—F237. http://dx.doi.org/10.1152/ajprenal.00080.2001.
Texto completo da fonteOzakca, Isil, Ebru Arioglu-Inan, Hrag Esfahani, V. Melih Altan, Jean-Luc Balligand, Gizem Kayki-Mutlu e A. Tanju Ozcelikay. "Nebivolol prevents desensitization of β-adrenoceptor signaling and induction of cardiac hypertrophy in response to isoprenaline beyond β1-adrenoceptor blockage". American Journal of Physiology-Heart and Circulatory Physiology 304, n.º 9 (1 de maio de 2013): H1267—H1276. http://dx.doi.org/10.1152/ajpheart.00352.2012.
Texto completo da fonteKruik-Kollöffel, Willemien J., Job van der Palen, Carine J. M. Doggen, Marissa C. van Maaren, H. Joost Kruik, Edith M. Heintjes, Kris L. L. Movig e Gerard C. M. Linssen. "Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases". PLOS ONE 15, n.º 12 (22 de dezembro de 2020): e0244231. http://dx.doi.org/10.1371/journal.pone.0244231.
Texto completo da fonteGutierrez, Guillermo, e Guillermo Ballarino. "Gut mucosal permeability, β1 receptor blockers and gastric tonometry: the time is now!" Intensive Care Medicine 37, n.º 11 (17 de agosto de 2011): 1721–22. http://dx.doi.org/10.1007/s00134-011-2330-1.
Texto completo da fonteNemoto, Shinji, Yusuke Kasahara, Kazuhiro P. Izawa, Satoshi Watanabe, Kazuya Yoshizawa, Naoya Takeichi, Kentaro Kamiya et al. "Effects of αβ-Blocker Versus β1-Blocker Treatment on Heart Rate Response During Incremental Cardiopulmonary Exercise in Japanese Male Patients with Subacute Myocardial Infarction". International Journal of Environmental Research and Public Health 16, n.º 16 (8 de agosto de 2019): 2838. http://dx.doi.org/10.3390/ijerph16162838.
Texto completo da fonteBrahmbhatt, Shruti Vihang, e Bhagya M. Sattigeri. "A study on management of hypertension in patients with type 2 diabetes mellitus in tertiary care teaching rural hospital". International Journal of Basic & Clinical Pharmacology 7, n.º 11 (23 de outubro de 2018): 2196. http://dx.doi.org/10.18203/2319-2003.ijbcp20184327.
Texto completo da fontePillozzi, Serena, Marika Masselli, Emanuele De Lorenzo, Benedetta Accordi, Emanuele Cilia, Olivia Crociani, Amedeo Amedei et al. "Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers". Blood 117, n.º 3 (20 de janeiro de 2011): 902–14. http://dx.doi.org/10.1182/blood-2010-01-262691.
Texto completo da fontePolakovičová, M., e R. Čižmáriková. "Molecular Docking Study on the Binding Mode of Cardioselective Phenoxyaminopropanol Blocker into β-adrenergic Receptor Subtypes". Acta Facultatis Pharmaceuticae Universitatis Comenianae 59, n.º 2 (28 de dezembro de 2012): 44–53. http://dx.doi.org/10.2478/v10219-012-0024-6.
Texto completo da fonteAhmed, Maruf, Habib Abul Muntasir, Murad Hossain, Masaji Ishiguro, Tadazumi Komiyama, Ikunobu Muramatsu, Hitoshi Kurose e Takafumi Nagatomo. "Beta-Blockers Show Inverse Agonism to a Novel Constitutively Active Mutant of β1-Adrenoceptor". Journal of Pharmacological Sciences 102, n.º 2 (2006): 167–72. http://dx.doi.org/10.1254/jphs.fp0060640.
Texto completo da fonteSong, Hong Ji, Joongyub Lee, Ye-Jee Kim, Sun-Young Jung, Hwa Jung Kim, Nam-Kyong Choi e Byung-Joo Park. "β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients". Bone 51, n.º 6 (dezembro de 2012): 1008–15. http://dx.doi.org/10.1016/j.bone.2012.08.126.
Texto completo da fonteBrizzi, Vittorio, Marco Francioli, Mario Brufani, Luigi Filocamo, Giancarlo Bruni e Paola Massarelli. "ChemInform Abstract: Synthesis, Binding Affinity, and Selectivity of New β1- and β2-Adrenoceptor Blockers." ChemInform 31, n.º 12 (9 de junho de 2010): no. http://dx.doi.org/10.1002/chin.200012248.
Texto completo da fonteJia, Haiyan, Sue Monteith e Morris J. Brown. "Expression of the α- and β-Subunits of the Stimulatory and Inhibitory G-Proteins in β1-Adrenoceptor-Blocked and non-β-Adrenoceptor-Blocked Human Atrium". Clinical Science 88, n.º 5 (1 de maio de 1995): 571–80. http://dx.doi.org/10.1042/cs0880571.
Texto completo da fonteGao, Xiaomeng, Jingyue Chang, Yi Chang, Lili Fan, Ziqian Liu, Cuijuan Zhang, Tatsuo Shimosawa, Fan Yang e Qingyou Xu. "Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice". International Journal of Molecular Sciences 24, n.º 14 (21 de julho de 2023): 11766. http://dx.doi.org/10.3390/ijms241411766.
Texto completo da fonte